Pharmaceutical Technology

MAY 2, 2023

Immuno-oncology (IO) agents have transformed the cancer therapeutics landscape, driving long-term remissions in a subset of patients who historically had limited options. IO agents include the classes of immune checkpoint modulators, cell therapies, bispecific antibodies, oncolytic viruses, therapeutic vaccines, and cytokines.

Physicians 52

Physicians Marketing Patients Manufacturing 52

Pharmaceutical Technology

APRIL 13, 2023

Released on April 12, the report focuses on bluebird bio’s lovotibeglogene autotemcel and Vertex Pharmaceuticals and CRISPR Therapeutics’ exagamglogene autotemcel or exa-cel and their potential use in treating sickle cell disease. Still, comparing the two therapies remains difficult, with ICER rating the evidence as insufficient.

Healthcare 59

Healthcare Healthcare Pharmaceutical FDA 59

Pharmaceutical Technology

APRIL 5, 2023

But access to these treatments continues to remain limited due to high price tags and variable availability across regions. This includes the first potential approval of a CRISPR-based gene therapy called exa-cel , which is developed by CRISPR Therapeutics and Vertex Pharmaceuticals. How can we better educate the patients?

Food and Drug Administration 59

Food and Drug Administration Engineering Patients Education 59

Rep-Lite

MARCH 21, 2024

Experienced medical sales reps who specialize in medical products or therapeutic areas may receive higher compensation due to their expertise and ability to provide value-added services to clients. There are rungs and each comes with both a price tag and an incentive. Size really does matter but not in the ways you might be thinking.

Medical sales 52

Medical sales Medical sales reps Medical Sales 52

European Pharmaceutical Review

NOVEMBER 10, 2022

Complex medicines offer diverse therapeutic modalities, including RNA therapeutics and antibody-drug conjugates (ADCs). Advanced light microscopy techniques can be used to better understand complex medicines and establish new approaches for discovery and development. Physical characterisation.

Medicine 90

Medicine Distribution Engineering Electronics 90

European Pharmaceutical Review

DECEMBER 27, 2023

Studies have since demonstrated significantly reduced CAR-associated CRS and other toxicities without jeopardising therapeutic yield and outcomes; 9 both G-CSF and tocilizumab are now part of daily practice in CART-cell therapy. This is in addition to its considerable price tag.

Manufacturing 78

Manufacturing Food and Drug Administration Patients Pharma 78

Pharma Marketing Network

JUNE 8, 2020

I mean, you know, there has obviously been a lot of breakthrough biologics and different therapeutics like around cancers and things like that, that have high price tags because maybe they don’t have as big a market as you know, something’s wrong, you know blood pressure medication.

Healthcare 40

Healthcare Healthcare Marketing Pharma 40